ARCHIVES

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Biomira Ends Agreement On Lymphoma Vaccine.

May 4, 2001

In Brief: More Money, Not Reorganization, Is Needed For Clinical Research, Paul Carbone Argues

November 10, 1978

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Symposium Planned On Hyperthermia

April 23, 1976

Herceptin With Chemo Increases Survival In Early-Stage Breast Cancer, Study Finds

December 30, 2005